<META NAME="ROBOTS" CONTENT="NOINDEX, FOLLOW"> 
<HTML>
<HEAD>

<link rel="stylesheet" type="text/css" href="style.css">
<link rel="stylesheet" type="text/css" href="tabcontent.css" >
<script type="text/javascript" src="tabcontent.js"></script>

</SCRIPT>
<TITLE>CTRI</TITLE>
</HEAD>
<body bgcolor="aliceblue">

<table width=100% border=0 cellspacing="0" cellpadding="2" align=center bgcolor="#eaeaea">
  
	<tr bgcolor="aliceblue">
		<td valign="top" height="90%" ><META NAME="ROBOTS" CONTENT="NOINDEX, FOLLOW"> 
<link rel="stylesheet" type="text/css" href="style.css">
<link rel="stylesheet" type="text/css" href="tabcontent.css" >
<LINK href="style.css" type=text/css rel=stylesheet>
<LINK href="style.css" type=text/css rel=stylesheet>
<style>
.highlight { background-color: yellow };
</style>
<script type="text/javascript">
     function newwin2(win,winname)
	 {
	    window.open(win,winname,"toolbar=no,menubar=no,directories=no,left=250,top=250,width=600 height=600,resizable=yes,scrollbars=yes")
	 }
     
     
   
     
</script>
<script language="javascript" src="jquery.js" type="text/javascript"></script>
<script language="javascript" src="jquery.highlight-3.js" type="text/javascript"></script>
<table width=100% border=0 cellspacing="0" cellpadding="2" align=center bgcolor="#eaeaea">
<tr>
    <td style="background-image: images/header.jpg; width: 100%;"><font face="verdana" size="-1"><b>FULL DETAILS (Read-only) &nbsp;->&nbsp;<a href="pdf_generate.php?trialid=59978&EncHid=&modid=&compid=','59978det'" TARGET="_blank">Click Here to Create PDF for Current Dataset of Trial</a></b></font></td>
</tr>
</table>



<table align=center width="100%" cellpadding="3" cellspacing="1" border="1" bordercolor="lightgrey">


<tr>
    <td><b>CTRI Number&nbsp;</td>
    <td><b>CTRI/2021/09/036162</b>&nbsp;[Registered on: 02/09/2021] <font color=green><b>Trial Registered Prospectively</b></font></td>
</tr>

<tr>
    <td><b>Last Modified On:</td>
    <td>01/09/2021</td>
</tr>

	<!--<tr>
	    <td><b>Acknowledgement Number&nbsp;</td>
	    <td>REF/2021/08/046721&nbsp;</td>
	</tr>


--><tr>
    <td><b>Post Graduate Thesis&nbsp;</td>
    <td>No&nbsp;</td>
</tr>


<tr>
    <td><b>Type of Trial&nbsp;</td>
    <td>Interventional&nbsp;</td>
</tr>


<tr>
    <td>
    <b>Type of Study</b>
       
         &nbsp;</td>
    <td>Homeopathy&nbsp;</td>
</tr>


<tr>
    <td><b>Study Design&nbsp;</td>
    <td>Randomized, Parallel Group, Active Controlled Trial&nbsp;</td>
</tr>

<tr>
    <td>
    <b>Public Title of Study</b>
     
     
    &nbsp;</td>
    <td>A Study to Evaluate Efficacy and Safety of a Combination of Homeopathic Medications as an Add on Therapy in Patients with Severe to Critical COVID-19 Infection&nbsp;</td>
</tr>

<tr>
    <td>
    <b>Scientific Title of Study</b>
      
         &nbsp;</td>
    <td>A Randomized, Open label Study to Evaluate Efficacy and Safety of a Combination of Homeopathic Medications as an Add on Therapy to Standard of Care in Patients with Severe to Critical SAR-COV-2 (COVID-19) Infection&nbsp;</td>
</tr>
<tr>
    <td><b>Trial Acronym</b>&nbsp;</td>
    <td>&nbsp;</td>
</tr>
<tr>
    <td>
    <b>Secondary IDs if Any</b>
      
         &nbsp;</td>
    <td>
    <table border="1" bordercolor="#858585" width="100%">
    <tr bgcolor="#004080">
        <td><font color="white"><B>Secondary ID&nbsp;</td>
        <td><font color="white"><B>Identifier&nbsp;</td>
    </tr>
            <tr>
            <td>NIL&nbsp;</td>
            <td>NIL&nbsp;</td>
        </tr>


    </table>
     
&nbsp;</td>
</tr>



<tr>
    <td>
    <b>Details of Principal Investigator or overall Trial Coordinator (multi-center study)</b>
                 
                        
           
         &nbsp;</td>
    <td>
        <table width="100%" border="1" bordercolor="#858585">
        <tr>
            <td><b>Name&nbsp;</td>
            <td>Prof Dr Sarman Singh&nbsp;</td>
        </tr>

	<tr>
            <td><b>Designation&nbsp;</td>
            <td>Director and CEO&nbsp;</td>
        </tr>

	<tr>
            <td><b>Affiliation&nbsp;</td>
            <td>All India Institute of Medical Sciences Bhopal&nbsp;</td>
        </tr>
	
        <tr>
            <td><b>Address&nbsp;</td>
            <td>Department of Clinical Microbiology, 

All India Institute of Medical Sciences, Bhopal<br /><br />Bhopal<br />MADHYA PRADESH<br />462020<br />India&nbsp;</td>
        </tr>        
        <tr>
            <td><b>Phone&nbsp;</td>
            <td>&nbsp;&nbsp;</td>
        </tr>        
        <tr>
            <td><b>Fax&nbsp;</td>
            <td>&nbsp;&nbsp;</td>
        </tr>        

        <tr>
            <td><b>Email&nbsp;</td>
            <td>director@aiimsbhopal.edu.in&nbsp;&nbsp;</td>
        </tr>                
        </table>
    &nbsp;</td>
</tr>


<tr>
    <td>
    <b>Details of Contact Person<br />Scientific Query</b>
      
         &nbsp;</td>
    <td>
        <table width="100%" border="1" bordercolor="#858585">
        <tr>
            <td>Name&nbsp;</td>
            <td> Dr Abhishek Singhai&nbsp;</td>
        </tr>


	<tr>
            <td><b>Designation&nbsp;</td>
            <td> Assistant Professor&nbsp;</td>
        </tr>

	<tr>
            <td><b>Affiliation&nbsp;</td>
            <td>All India Institute of Medical Sciences Bhopal&nbsp;</td>
        </tr>

        <tr>
            <td><b>Address&nbsp;</td>
            <td>Department of General medicine, All India Institute of Medical Sciences Bhopal<br /><br />Bhopal<br />MADHYA PRADESH<br />462020<br />India&nbsp;</td>
        </tr>        
        <tr>
            <td><b>Phone&nbsp;</td>
            <td>&nbsp;&nbsp;</td>
        </tr>        
        <tr>
            <td><b>Fax&nbsp;</td>
            <td>&nbsp;&nbsp;</td>
        </tr>        

        <tr>
            <td><b>Email&nbsp;</td>
            <td>abhishek.genmed@aiimsbhopal.edu.in&nbsp;&nbsp;</td>
        </tr>                
        </table>
    &nbsp;</td>
</tr>



<tr>
    <td>
    <b>Details of Contact Person<br />Public Query</b>
       
         &nbsp;</td>
    <td>
        <table width="100%" border="1" bordercolor="#858585">
        <tr>
            <td><b>Name&nbsp;</td>
            <td>Dr Ashish Kumar Dixit&nbsp;</td>
        </tr>


		<tr>
            <td><b>Designation&nbsp;</td>
            <td>Medical Officer (Homoeopathy)&nbsp;</td>
        </tr>

	<tr>
            <td><b>Affiliation&nbsp;</td>
            <td>All India Institute of Medical Sciences Bhopal&nbsp;</td>
        </tr>


        <tr>
            <td><b>Address&nbsp;</td>
            <td>Department of AYUSH, All India Institute of Medical Sciences Bhopal<br /><br />Bhopal<br />MADHYA PRADESH<br />462020<br />India&nbsp;</td>
        </tr>        
        <tr>
            <td><b>Phone&nbsp;</td>
            <td>&nbsp;&nbsp;</td>
        </tr>        
        <tr>
            <td><b>Fax&nbsp;</td>
            <td>&nbsp;&nbsp;</td>
        </tr>        

        <tr>
            <td><b>Email&nbsp;</td>
            <td>ashish.ayush@aiimsbhopal.edu.in&nbsp;&nbsp;</td>
        </tr>                
        </table>
    &nbsp;</td>
</tr>

<tr>
    <td>
    <b>Source of Monetary or Material Support</b>
       
         &nbsp;</td>
    <td>
    <table border="1" bordercolor="#858585" width="100%">
    
            <tr>
            <td>Dr Manoj Kuriakose, Hyderabad and All India Institute of Medical Sciences Bhopal&nbsp;</td>
    
        </tr>


    </table>
     
&nbsp;</td>
</tr>
<tr>
    <td>
    <b>Primary Sponsor</b>
                  
                        
           
         &nbsp;</td>
    <td>
        <table width="100%" border="1" bordercolor="#858585">
        <tr>
            <td><b>Name&nbsp;</td>
            <td>Dr Manoj Kuriakose&nbsp;</td>
        </tr>            
        <tr>
            <td><b>Address&nbsp;</td>
            <td>Avenue 6, Behind Care Hospital, Banjara Hills, Hyderabad 500034 &nbsp;</td>
        </tr>
        <tr>
            <td><b>Type of Sponsor&nbsp;</td>
                        <td>Other&nbsp;[Self]&nbsp;</td>
        </tr>
        </table>
    &nbsp;</td>
</tr>
<tr>
    <td>
    <b>Details of Secondary Sponsor</b>
       
         &nbsp;</td>
    <td>
        <table width="100%" border="1" bordercolor="#858585">
            <tr bgcolor="#004080">
                <td><font color="white"><b>Name&nbsp;</td>
                <td><font color="white"><b>Address&nbsp;</td>
            </tr>
            <tr>
                <td>All India Institute of Medical Sciences Bhopal&nbsp;</td>
                <td>All India Institute of Medical Sciences, Saket Nagar, Bhopal 462020&nbsp;</td>
            </tr>

        </table>
    &nbsp;</td>
</tr>
<tr>
    <td>
    <b>Countries of Recruitment</b>
       
         &nbsp;</td>
    <td>&nbsp;
   India &nbsp;</td>
   </tr>
<tr>
    <td>
    <b>Sites of Study</b>
                  
                        
           
         &nbsp;</td>
    <td>
    	<table width="100%" border="1" bordercolor="lightgrey">
    <tr bgcolor="black">
           <td colspan="4" align="center"><font size="2" color="white">No of Sites = <b>1 &nbsp;</td>
    </tr>

    <tr bgcolor="#004080">
        <td><b><font color="white">Name of Principal
Investigator&nbsp;</td>
        <td><b><font color="white">Name of Site&nbsp;</td>
        <td><b><font color="white">Site Address&nbsp;</td>
        <td><b><font color="white">Phone/Fax/Email&nbsp;</td>
    </tr>
    	

        <tr>
        <td>Prof Dr Sarman Singh&nbsp;</td>
        <td>Departments of General Medicine and Trauma & Emergency Medicine&nbsp;</td>
        <td>All India Institute of Medical Sciences, Saket Nagar, Bhopal<br />Bhopal<br />MADHYA PRADESH&nbsp;</td>
        <td>0755-2672317<br /><br />director@aiimsbhopal.edu.in&nbsp;</td>
    </tr>
                
        </table>
    &nbsp;</td>
</tr>
<tr>
    <td>
    <b>Details of Ethics Committee
       
         &nbsp;</td>
    <td>
        <table width="100%" border="1" bordercolor="lightgrey">

    <tr bgcolor="black">
           <td colspan="5" align="center"><font size="2" color="white">No of Ethics Committees= <b>1 &nbsp;</td>
    </tr>
           <tr bgcolor="#004080">
                <td><b><font color="white">Name of Committee&nbsp;</td>
                <td><b><font color="white">Approval Status&nbsp;</td>
               <!-- <td><b><font color="white">Date of Approval&nbsp;</td>
                <td><b><font color="white">Approval Document&nbsp;</td>
                <td><b><font color="white">Is IEC?&nbsp;</td>-->
            </tr>
            <tr>
                <td>All India Institute of Medical Sciences Bhopal Institutional Human Ethics Committee&nbsp;</td>
                <td>Approved&nbsp;</td>
              <!--  <td>16/08/2021&nbsp;</td>               
                <td><a target=_blank href=http://ctri.nic.in/Clinicaltrials//WriteReadData/ethic/790896005LOPEF0247.pdf>Approval File</a>&nbsp;</td>
                <td>No&nbsp;</td>-->
            </tr>        

        </table>
    &nbsp;</td>
</tr>
<tr>
    <td>
    <b>Regulatory Clearance Status from DCGI</b>
       
         &nbsp;</td>
        <td>
        <table width="100%" border="1" bordercolor="lightgrey">
            <tr bgcolor="#004080">
                <td><font color="white"><b>Status&nbsp;</td>
                <!--<td><font color="white"><b>Date&nbsp;</td>
                <td><font color="white"><b>Aproval Document&nbsp;</td>-->
            </tr>
            <tr>
                <td>Not Applicable&nbsp;</td>
             <!--   <td>No Date Specified&nbsp;</td>
                <td>No File Uploaded&nbsp;</td>          -->      
            </tr>
        </table>
    &nbsp;</td>
</tr>
<tr>
    <td>
    <b>Health Condition / Problems Studied</b>
                  
                        
           
         &nbsp;</td>
    <td>
        <table width="100%" border="1" bordercolor="lightgrey">
            <tr bgcolor="#004080">
                <td><font color="white"><b>Health Type&nbsp;</td>
                <td><font color="white"><b>Condition&nbsp;</td>
            </tr>
	<tr>
    		<td>Patients&nbsp;</td>
    		<td><font color='red'><b>(1) </b></font><font color='green'><b>ICD-10 Condition: </b></font>B972||Coronavirus as the cause of diseases classified elsewhere, &nbsp;</td>
  	</tr>
	
        </table>
    &nbsp;</td>
</tr>

<tr>
    <td>
    <b>Intervention / Comparator Agent</b>
       
         &nbsp;</td>
    <td>
        <table width="100%" border="1" bordercolor="lightgrey">
            <tr bgcolor="#004080">
                <td><font color="white"><b>Type&nbsp;</td>
                <td><font color="white"><b>Name&nbsp;</td>
                <td><font color="white"><b>Details&nbsp;</td>
            </tr>
  <tr>
    <td>Intervention&nbsp;</td>
    <td>Combination of homeopathic medication &nbsp;</td>
    <td>Combination of homeopathic medication (Arsenicum Album +Bryonia Alba + Phosphorus)&nbsp;</td>
  </tr>
    <tr>
    <td>Comparator Agent&nbsp;</td>
    <td>Standard of Care (SOC)&nbsp;</td>
    <td>The Standard of Care (SOC) will be given as per the recent guidelines for management of COVID 19 infection and may include 

-	Symptomatic treatment 

-	Oxygenation 

-	Conservative fluid management.

-	Corticosteroids: IV Methylprednisolone 1-2 mg/kg or Dexamethasone 0.2-0.4 mg/kg for 5-7 days

-	Anti-IL-6 therapy such as tocilizumab

&nbsp;</td>
  </tr>
          </table>
    &nbsp;</td>
</tr>

<tr>
    <td>
    <b>Inclusion Criteria</b>
       
              &nbsp;</td>
    <td>
        <table width="100%" border="1" bordercolor="lightgrey">
            <tr>
                <td><b>Age From</b>&nbsp;</td>
                <td>18.00&nbsp;Year(s)</td>
            </tr>
            <tr>
                <td><b>Age To</b>&nbsp;</td>
                <td>99.00&nbsp;Year(s)</td>
            </tr>
                        <tr>
                <td><b>Gender</b>&nbsp;</td>
                <td>Both&nbsp;</td>
            </tr>       
            <tr>
                <td><b>Details</b>&nbsp;</td>
                <td>1.	Subject (or legally authorized representative) provides informed consent prior to initiation of any study procedures.<br/>
2.	Male and female subjects greater than 18 years of age.<br/>
3.	 Has laboratory-confirmed SARS-CoV-2 infection as determined by RT-PCR, Rapid    Antigen Test, CBNAAT or CT suggestive of Pneumonia (CO-RADS 5 grade). <br/>
4.	 Adult with radiological signs of pneumonia (chest x-ray, CT scan, etc.) plus one of the following. <br/>
a.	respiratory rate >30 breaths/min, <br/>
b.	severe respiratory distress, <br/>
c.	SpO2 <90% on room air.<br/>
d.	With/without Oxygenation impairment: (Mild ARDS: 200 mmHg < PaO2/FiO2 â¤ 300 mmHg (with PEEP or CPAP â¥5 cm H2O); Moderate ARDS: 100 mmHg < PaO2/FiO2 â¤200 mmHg with PEEP â¥5 cm H2O); Severe ARDS: PaO2/FiO2 â¤ 100 mmHg with PEEP â¥5 cm H2O)<br/>
5.	Patient with or without pre-existing significant co-morbidities (e.g. lung diseases, diabetes, hypertension) at the discretion of the investigator. <br/>
6.	Women of childbearing potential and men who partner with a woman of childbearing potential must agree to use contraceptive methods.<br/>
7.	Willingness and ability to comply with trial and follow-up procedures.<br/>
8.	Ability to understand the nature of the trial and give written informed consent.<br/>
&nbsp;</td>
            </tr>     
        </table>
    &nbsp;</td>
</tr>
<tr>
    <td><b>ExclusionCriteria&nbsp;</td>
    <td>
        <table width="100%" border="1" bordercolor="lightgrey">

	            <!--tr>
                <td><b>Age From</b>&nbsp;</td>
                <td>1.00&nbsp;Day(s)</td>
            </tr-->
            <!--tr>
                <td><b>Age To</b>&nbsp;</td>
                <td>1.00&nbsp;Day(s)</td>
            </tr-->
                        <!--tr>
                <td><b>Gender</b>&nbsp;</td>
                <td>Both&nbsp;</td>
            </tr-->       
            <tr>
                <td><b>Details</b>&nbsp;</td>
                <td>1.	Patient with mild-moderate COVID-19 infection <br/>
2.	Patients who are allergic to arsenic album products<br/>
3.	Severely immunocompromised patients for example patients with a history of HIV infection, patients with solid organ transplantation or bone marrow transplantation, patients receiving chemotherapy/radiotherapy, patients with primary immunodeficiency.<br/>
4.	ALT/AST > 5 times the upper limit of normal. <br/>
5.	Stage 4 severe chronic kidney disease or requiring dialysis (eGFR <30 ml/min)<br/>
6.	Subjects who is receiving Covid-19 directed alternative medication (e.g. Any ayurvedic, Unani or homeopathic) <br/>
7.	Participation of patient in other investigational clinical studies <br/>
8.	Pregnant or breastfeeding.<br/>
9.	Concomitant disease or condition that could interfere with the conduct of the study, or for which the treatment could interfere with the conduct of the study, or that would in the opinion of investigator, pose an unacceptable risk to the subject in this study.<br/>
10.	Inability or unwillingness to comply with study and/or follow-up procedures outlined in the protocol.<br/>
11.	Psychological, familial, sociological, or geographical conditions that do not permit compliance with the protocol.<br/>
&nbsp;</td>
            </tr>     
        </table>
    &nbsp;</td>
</tr>
<tr>
    <td>
    <b>Method of Generating Random Sequence</b>
       
         &nbsp;</td>
    <td>Computer generated randomization&nbsp;</td>
</tr>

<tr>
    <td>
    <b>Method of Concealment</b>
       
         &nbsp;</td>
    <td>On-site computer system&nbsp;</td>
</tr>

<tr>
    <td>
    <b>Blinding/Masking</b>
       
         &nbsp;</td>
    <td>Open Label&nbsp;</td>
</tr>


<tr>
    <td>
    <b>Primary Outcome</b>
       
         &nbsp;</td>
    <td>
        <table width="100%" border="1" bordercolor="lightgrey">
             <tr bgcolor="#004080">
                <td><font color="white"><b>Outcome&nbsp;</td>
                <td><font color="white"><b>TimePoints&nbsp;</td>                
            </tr>
            <tr>
                <td>â	Patient clinical status (8-point ordinal scale) at Day 15.<br/>
1.	Death<br/>
2.	Hospitalized, on invasive mechanical ventilation or ECMO<br/>
3.	Hospitalized, on non-invasive ventilation or high flow oxygen devices<br/>
4.	Hospitalized, requiring supplemental oxygen<br/>
5.	Hospitalized, not requiring supplemental oxygen - requiring ongoing medical care (COVID-19 related or otherwise)<br/>
6.	Hospitalized, not requiring supplemental oxygen - no longer requires ongoing medical care.<br/>
7.	Not hospitalized, limitation on activities and/or requiring home oxygen<br/>
8.	Not hospitalized, no limitations on activities<br/>
&nbsp;</td>
                <td>at day 15&nbsp;</td>
            </tr>
        </table>
    &nbsp;</td>
</tr>

<tr>
    <td>
    <b>Secondary Outcome</b>
       
         &nbsp;</td>
    <td>
        <table width="100%" border="1" bordercolor="lightgrey">
             <tr bgcolor="#004080">
                <td><font color="white"><b>Outcome&nbsp;</td>
                <td><font color="white"><b>TimePoints&nbsp;</td>                
            </tr>
                <tr>
                <td>â	To assess the Clinical Severity:<br/>
1.	Ordinal scale:<br/>
-	Time to an improvement of one category from admission using an ordinal scale.<br/>
-	Subject clinical status using ordinal scale at Days 3, 5, 8, 11, and 29.<br/>
(Ordinal outcome will be assessed daily while hospitalized and on Days 15, 22 and 29)<br/>
2.	 National Early Warning Score (NEWS):<br/>
-	The time to discharge or to a NEWS of â¤ 2 and maintained for   24 hours, whichever occurs first.<br/>
(NEWS will be assessed daily while hospitalized and on Days 15, 22 and 29)<br/>
3.	Length of stay<br/>
-	Length of stay (ICU or ward)in days.<br/>
4.	Mortality in ICU patients <br/>
5.	 Need of admitting to ICU for patients admitted in wards.<br/>
â	To evaluate the safety <br/>
-	Incidence of serious adverse events (SAEs)<br/>
-	Incidence of Grade 3 and 4 adverse events (AEs).<br/>
-	Discontinuation or temporary suspension of study drug (for any reason).<br/>
&nbsp;</td>
                <td>1. Subject clinical status using ordinal scale at Days 3, 5, 8, 11, and 29.<br/>
(Ordinal outcome will be assessed daily while hospitalized and on Days 15, 22 and 29)<br/>
2.National Early Warning Score (NEWS):<br/>
-	The time to discharge or to a NEWS of â¤ 2 and maintained for   24 hours, whichever occurs first.<br/>
(NEWS will be assessed daily while hospitalized and on Days 15, 22 and 29<br/>
&nbsp;</td>
            </tr>
            <tr>
                <td>âPercentage change in the biomarkers such as IL-4, IL-6, CRP, ferritin, d-dimer and troponin C&nbsp;</td>
                <td>on day 1,3,5,8 and 11&nbsp;</td>
            </tr>
        </table>
    &nbsp;</td>
</tr>

<tr>
    <td>
    <b>Target Sample Size</b>
       
         &nbsp;</td>
    <td><b>Total Sample Size=</b>"30"<br /><b>Sample Size from India=</b>"30"&nbsp;<br /> 
<b>Final Enrollment numbers achieved (Total)=</b> "Applicable only for Completed/Terminated trials" <br /> 
<b>Final Enrollment numbers achieved (India)=</b>"Applicable only for Completed/Terminated trials"&nbsp;</td>
</td>
</tr>

<tr>
    <td>
    <b>Phase of Trial</b>
       
         &nbsp;</td>
    <td>Phase 2&nbsp;</td>
</tr>


<tr>
    <td>
    <b>Date of First Enrollment (India)</b>
       
         &nbsp;</td>
    <td>01/10/2021&nbsp;</td>
</tr>

<tr>	
<td><b>Date of Study Completion (India)</b></td>
	<td>Applicable only for Completed/Terminated trials&nbsp;</td>
</tr>

<tr>
    <td><b>Date of First Enrollment (Global)</b>&nbsp;</td>
    <td>Date Missing&nbsp;</td>
</tr>


<tr>	
<td><b>Date of Study Completion (Global)</b></td>
	<td>Applicable only for Completed/Terminated trials&nbsp;</td>
</tr>


<tr>
    <td>
    <b>Estimated Duration of Trial</b>
       
         &nbsp;</td>
    <td><b>Years=</b>"1"<br /><b>Months=</b>"0"<br /><b>Days=</b>"0"&nbsp;</td>
</tr>

<tr>
    <td>
    <b>Recruitment Status of Trial (Global)</b>
                  
                        
           
         &nbsp;</td>
    <td>Not Applicable&nbsp;</td>
</tr>

<tr>
    <td><b>Recruitment Status of Trial (India)</b>&nbsp;</td>
    <td>Not Yet Recruiting&nbsp;</td>
</tr>

<tr>
    <td>
    <b>Publication Details</b>
                     
                        
           
         &nbsp;</td>
    
    
    
    
    
    <td>Nil&nbsp;</td>
</tr>









	

<tr>
<td>
    <b> Individual Participant Data (IPD) Sharing Statement</b>
</td>
<td>

	
      <div style="width:100%;">
    <div style="margin-left:0px; width:100%;">
        <p><b>Will individual participant data (IPD) be shared publicly (including data dictionaries)? &nbsp;</b></p>
                   <b>Response</b>&nbsp;-&nbsp;NO         </div>
        </div>
   










<tr>
    <td>
    <b>Brief Summary</b>
       
         &nbsp;</td>
    <td><h1 style="text-align: justify; margin: 0cm 5.65pt 0.0001pt 1cm; break-after: avoid;"><font face="Arial" style="font-weight: normal;" size="2">This is a randomized, open-label, two-arm study of the combination of homoeopathic medications as add-on therapy in patients with severe to critical COVID-19  infection being conducted at AIIMS Bhopal.&nbsp;The objective of this study is to assess the efficacy and safety of a homoeopathic medication combination as add-on therapy in severe COVID 19 patients, as assessed by the Clinical Severity-Ordinal scale, the National Early Warning Score (NEWS), oxygenation, mechanical ventilation, hospitalisation, and mortality. Additionally, to assess changes in inflammatory markers.</font></h1><p class="MsoNormal" style="margin-left:1.0cm;text-align:justify;mso-layout-grid-align:  none;text-autospace:none"><span lang="EN-US" style="font-size:12.0pt"><o:p></o:p></span></p>&nbsp;</td>
</tr>

</table>
<center><a href=javascript:(window.close())>Close</a></center>
</td>
	</tr>
</table> 


	
</body>
</HTML>
